Sanjay Bindra, MD
Cardiac Electrophysiology · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 1 carrier
- Offices
- 5
- Since medical school
- 29 years
- Graduated 1997
Offices
5 locations · County of San Mateo · Altru Health System · St. Luke'S Hospital of Duluth
Looking this up.
Hospitals listed: Altru Hospital · Aspirus St Lukes Hospital · Mills-Peninsula Medical Center · San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bindra’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A72359 · Current
Licensed to practise in California · since 2000 · expires 2027-11-30 · University of Mumbai, Seth G. S. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Altru HospitalGrand Forks, NDAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Altru Health System, which runs 2 hospitalsPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.282, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.284, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- St Lukes HospitalDuluth, MNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes Hospital of Duluth, which runs 2 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.301, Oct 2024 – Sep 2025
See every measure and the patient survey for Altru Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.282 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.284 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.84 (0 to 1.82) · 1,024 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.6 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.96 (118.01 to 221.92) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 73 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.3 · 370 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.1 · 164 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,461 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.36) · 5,714 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.14 to 0.53) · 5,858 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.56 (0.58 to 4.55) · 1,506 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.73 (0.17 to 3.28) · 430 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (0.88 to 3.77) · 1,388 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.29 (0 to 11.95) · 435 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.96 (0.19 to 7.74) · 402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.12 to 3.01) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.02 (0.37 to 1.66) · 4,995 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.445 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.312 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.265 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 191 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 418 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17 · 158 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -29 · 415 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -16 · 618 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 655 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.2) · 307 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.8 to 14.7) · 307 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 124 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.8 to 15.9) · 1,812 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 1,137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (906 patients answered, 25% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 78% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for St Lukes Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.301 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 664 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.51 to 1.19) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.95 (86.18 to 193.72) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.5 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.4 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 20.6 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.4 · 266 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,941 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,538 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.36 (0.15 to 0.56) · 3,580 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.82 (0.6 to 5.03) · 954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.24 (0.63 to 3.84) · 502 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.89) · 929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.07 (1.34 to 14.8) · 511 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.18 (1.49 to 8.87) · 458 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 176 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,952 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 170 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.614 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.709 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.979 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 282 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.8 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.5 · 145 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 21.1 · 174 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22.8 · 160 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 401 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.1 to 6.9) · 168 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (8.2 to 15) · 168 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 178 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 79 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 238 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.3) · 939 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
What patients said (388 patients answered, 22% of those asked)
| Cleanliness | 1 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$24,841
Medicare paid this office $24,841 for 448 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 93 | $4,735 | $51 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $4,567 | $351 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 272 | $1,857 | $6 |
| Insertion of heart rhythm monitor under skin | 14 | $814 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $306 | $9 |
See all 6 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 93 | $4,735 | $51 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $4,567 | $351 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 272 | $1,857 | $6 |
| Insertion of heart rhythm monitor under skin | 14 | $814 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $306 | $9 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $123 | $10 |
Procedures Medicare counted
| Pacemaker insertion or repair | 11 | More than 62% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of heart rhythm monitor under skin | – | – | – | 18 | 17 | 14 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | – | – | – | – | 13 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
448 Original Medicare patients in 2024. Average age 72 · Under 65 11% · 85 and older 11% · Women 50% · Also on Medicaid 75% · Health risk score 1.47. At or below the middle of the specialty; the typical cardiac surgery clinician is at 1.73.
Conditions among them: High blood pressure 75% · Diabetes 38% · Coronary heart disease 33% · Atrial fibrillation 27% · Heart failure 26% · Chronic kidney disease 24% · Depression 23% · COPD 19% · Cancer 13% · Dementia 10% · Stroke 8%.
The office billed $189,723, Medicare allowed $33,764 and paid $24,841; for 616 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 448 | 616 | 72 | 1.47 | $189,723 | $24,841 |
| 2023 | 416 | 623 | 73 | 1.49 | $257,212 | $25,275 |
| 2022 | 463 | 676 | 72 | 1.67 | $275,314 | $26,721 |
| 2021 | 362 | 560 | 71 | 1.64 | $168,793 | $20,619 |
| 2020 | 257 | 360 | 71 | 1.81 | $110,538 | $11,113 |
| 2019 | 630 | 1,802 | 77 | 2.08 | $368,879 | $109,904 |
| 2018 | 375 | 3,036 | 76 | 2.34 | $432,656 | $190,437 |
| 2017 | 511 | 2,204 | 75 | 2.58 | $434,769 | $174,773 |
| 2016 | 367 | 1,551 | 75 | 2.21 | $551,788 | $150,443 |
| 2015 | 355 | 1,207 | 76 | 2.47 | $356,809 | $105,920 |
| 2014 | 408 | 1,906 | 76 | 2.22 | $415,406 | $148,417 |
| 2013 | 399 | 1,433 | 75 | 2.24 | $398,369 | $135,405 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $5,278 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 227 | $1,660 | $6 |
| Insertion of heart rhythm monitor under skin | 17 | $1,087 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $954 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $222 | $9 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 16 | $214 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $174 | $12 |
2022: 10 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 116 | $6,346 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,717 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 233 | $1,613 | $6 |
| Insertion of heart rhythm monitor under skin | 18 | $1,115 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $646 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $338 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $309 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $229 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $170 | $9 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $103 | $9 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $4,697 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $3,431 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,996 | $176 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 226 | $1,745 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,284 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $218 | $16 |
2020: 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 70 | $4,614 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 135 | $1,099 | $7 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $936 | $72 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $292 | $22 |
| Short return visit (20+ min) | 12 | $271 | $23 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $100 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $44 | $3 |
2019: 24 services
| Short return visit (20+ min) | 143 | $14,977 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $12,385 | $179 |
| New patient visit (45+ min) | 43 | $6,304 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $5,948 | $198 |
| Return visit (30+ min) | 48 | $5,720 | $97 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,546 | $396 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,366 | $488 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $3,537 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 106 | $3,127 | $24 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 23 | $2,177 | $20 |
| Return visit (30+ min) | 33 | $2,088 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,991 | $64 |
| New patient visit (45+ min) | 19 | $1,890 | $99 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 32 | $1,539 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 36 | $1,464 | $34 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 11 | $1,050 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 26 | $891 | $21 |
| Short return visit (20+ min) | 14 | $673 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 71 | $524 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $467 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 19 | $321 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $272 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $193 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $67 | $6 |
2018: 29 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 18 | $27,746 | $1,541 |
| Short return visit (20+ min) | 143 | $16,486 | $62 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 18 | $14,404 | $400 |
| New patient visit (45+ min) | 85 | $11,177 | $131 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $11,102 | $694 |
| Return visit (30+ min) | 88 | $10,346 | $96 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 21 | $8,787 | $418 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $8,588 | $118 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 24 | $7,173 | $276 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $6,765 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $5,629 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,490 | $173 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 57 | $3,480 | $61 |
| Programming of heart rhythm stimulation after drug infusion | 23 | $3,244 | $135 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 23 | $2,966 | $21 |
| Implantation patient-activated heart monitoring device | 11 | $1,747 | $159 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 12 | $1,303 | $100 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 19 | $1,301 | $68 |
| Return visit (30+ min) | 16 | $1,227 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $1,218 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 17 | $791 | None |
| Injection of drug or substance into vein | 16 | $755 | $47 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 47 | $516 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $403 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $331 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $329 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $197 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $132 | $12 |
| Infusion, normal saline solution, 250 cc | 19 | $73 | None |
2017: 22 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $14,227 | $176 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $14,013 | $412 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $11,261 | $704 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 178 | $10,514 | $58 |
| Return visit (30+ min) | 97 | $10,484 | $88 |
| Short return visit (20+ min) | 109 | $10,275 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $8,513 | $120 |
| New patient visit (45+ min) | 54 | $7,778 | $144 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 21 | $7,592 | $345 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $6,502 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,480 | $64 |
| Programming of heart rhythm stimulation after drug infusion | 24 | $3,491 | $140 |
| Long return visit (40+ min) | 15 | $2,020 | $126 |
| New patient visit (60+ min) | 12 | $1,961 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $1,866 | $156 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,440 | $103 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $1,379 | $22 |
| Programming of dual lead pacemaker system | 17 | $1,133 | $52 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 91 | $1,011 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 31 | $630 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $451 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 31 | $431 | $13 |
2016: 19 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 22 | $15,833 | $688 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 100 | $12,311 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 103 | $11,621 | $61 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 28 | $11,464 | $409 |
| Return visit (30+ min) | 74 | $9,562 | $95 |
| Short return visit (20+ min) | 94 | $9,038 | $57 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 23 | $8,220 | $329 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,302 | $170 |
| New patient visit (45+ min) | 41 | $5,280 | $129 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 93 | $5,173 | $54 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,267 | $388 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $4,192 | $299 |
| Programming of heart rhythm stimulation after drug infusion | 23 | $3,301 | $132 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 22 | $2,140 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,687 | $89 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $1,484 | $21 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 120 | $1,300 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $326 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $188 | $13 |
2015: 13 services
| Short return visit (20+ min) | 142 | $18,823 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $13,657 | $61 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $10,332 | $413 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $7,833 | $163 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,698 | $700 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $5,350 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,019 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $3,732 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $3,065 | $204 |
| New patient visit (45+ min) | 16 | $2,171 | $136 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $1,989 | $133 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 24 | $306 | $6 |
| Insertion of needle into vein for collection of blood sample | 12 | $44 | $3 |
2014: 23 services
| Short return visit (20+ min) | 146 | $21,944 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 139 | $19,100 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $19,042 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 99 | $16,965 | $165 |
| Insertion of implantable defibrillator system | 11 | $8,177 | $743 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,593 | $412 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $5,380 | $54 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,050 | $459 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $3,623 | $201 |
| New patient visit (45+ min) | 24 | $3,273 | $136 |
| Initial hospital observation care per day, typically 70 minutes | 20 | $2,901 | $145 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 11 | $2,900 | $132 |
| Long return visit (40+ min) | 20 | $2,548 | $127 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 14 | $2,448 | $175 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 35 | $2,414 | $69 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,727 | $133 |
| Return visit (30+ min) | 14 | $1,340 | $89 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,086 | $90 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 16 | $229 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 15 | $212 | $13 |
| Blood test, basic group of blood chemicals (calcium, total) | 13 | $208 | $10 |
| Hemoglobin a1c level | 11 | $169 | $13 |
| Insertion of needle into vein for collection of blood sample | 24 | $94 | $3 |
2013: 20 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 119 | $20,881 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $17,926 | $61 |
| Short return visit (20+ min) | 106 | $15,840 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $14,266 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $5,607 | $53 |
| Return visit (30+ min) | 57 | $5,547 | $89 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,338 | $485 |
| Initial hospital observation care per day, typically 70 minutes | 29 | $4,052 | $135 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $3,251 | $171 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 11 | $2,911 | $132 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,122 | $88 |
| Programming of heart rhythm stimulation after drug infusion | 14 | $1,816 | $130 |
| Initial hospital observation care per day, typically 50 minutes | 12 | $1,586 | $113 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,072 | $67 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $343 | $21 |
| Blood test, thyroid stimulating hormone (tsh) | 14 | $341 | $23 |
| Blood test, lipids (cholesterol and triglycerides) | 13 | $185 | $14 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 13 | $168 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $148 | $12 |
| Insertion of needle into vein for collection of blood sample | 20 | $80 | $3 |
Medicaid work
$111,382 in 2024
Medicaid paid $111,382 for 3,214 billed services this clinician did in 2024, up to 227 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 566 | $52,334 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,205 | $35,551 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 281 | $19,224 |
| CARDIOVASCULAR STRESS TEST | 89 | $1,876 |
| Short return visit (20+ min) | 17 | $1,218 |
| XTRNL ECG REC<48 HR R&I | 27 | $798 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 16 | $381 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
| 2024 | 3,214 | 8 | 227 | $111,382 |
| 2023 | 3,664 | 9 | 229 | $95,199 |
| 2022 | 3,304 | 9 | 202 | $93,637 |
| 2021 | 2,462 | 6 | 152 | $60,676 |
| 2020 | 1,510 | 4 | 122 | $42,215 |
| 2019 | 45 | 2 | 22 | $570 |
| 2018 | 15 | 1 | 15 | $0 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,331 | $35,520 |
| Return visit (30+ min) | 695 | $29,597 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 272 | $17,581 |
| New patient visit (45+ min) | 69 | $5,570 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 94 | $2,239 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 116 | $2,185 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 29 | $1,234 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 40 | $893 |
| CARDIOVASCULAR STRESS TEST | 18 | $380 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,029 | $30,969 |
| Return visit (30+ min) | 669 | $28,115 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 361 | $24,421 |
| New patient visit (45+ min) | 67 | $5,591 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 32 | $1,433 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 62 | $1,242 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 45 | $1,050 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 26 | $536 |
| CARDIOVASCULAR STRESS TEST | 13 | $281 |
2021
| Return visit (30+ min) | 591 | $24,156 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,649 | $23,947 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 147 | $8,999 |
| New patient visit (45+ min) | 33 | $2,641 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 30 | $650 |
| XTRNL ECG REC<48 HR R&I | 12 | $282 |
2020
| Return visit (30+ min) | 353 | $15,023 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 950 | $13,310 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 148 | $9,257 |
| New patient visit (45+ min) | 59 | $4,625 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $374 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 30 | $196 |
2018
| Short return visit (20+ min) | 15 | $0 |
Drugs they prescribed that Part D paid
$592,659
Pharmacies billed $592,659 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,784) in 2024. At or below the middle of the specialty; the typical cardiac surgery clinician is at 0%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
1,308 generic and 476 brand-name prescriptions · $592,659 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 273 | $303,112 | $1,110 |
| Eliquis | 102 | $157,838 | $1,547 |
| Xarelto | 40 | $52,274 | $1,307 |
| Entresto | 41 | $48,872 | $1,192 |
| Atorvastatin | 215 | $5,135 | $24 |
See all 21 drugs
| Jardiance | 273 | $303,112 | $1,110 |
| Eliquis | 102 | $157,838 | $1,547 |
| Xarelto | 40 | $52,274 | $1,307 |
| Entresto | 41 | $48,872 | $1,192 |
| Atorvastatin | 215 | $5,135 | $24 |
| Ezetimibe | 50 | $4,146 | $83 |
| Metoprolol | 206 | $2,695 | $13 |
| Clopidogrel | 60 | $2,172 | $36 |
| Rosuvastatin | 38 | $2,096 | $55 |
| Losartan | 129 | $1,954 | $15 |
| Labetalol | 18 | $923 | $51 |
| Amlodipine Besylate | 92 | $820 | $9 |
| Hydralazine | 33 | $631 | $19 |
| Spironolactone | 63 | $467 | $7 |
| Carvedilol | 37 | $425 | $11 |
| Lisinopril | 62 | $385 | $6 |
| Furosemide | 77 | $295 | $4 |
| Isosorbide Mononitrate Er | 17 | $281 | $17 |
| Hydrochlorothiazide | 50 | $80 | $2 |
| Omeprazole | 12 | $42 | $3 |
| Metoprolol | 11 | $40 | $4 |
Year by year
| 2024 | 1,784 | 267 | 0% (0) | 27% | $592,659 |
| 2023 | 1,749 | 244 | 0% (0) | 21% | $457,663 |
| 2022 | 1,512 | 218 | 0% (0) | None | $264,364 |
| 2021 | 1,243 | 217 | 0% (0) | 13% | $149,788 |
| 2020 | 1,060 | 246 | 0% (0) | 18% | $130,697 |
| 2019 | 1,138 | 197 | 0% (0) | None | $149,433 |
| 2018 | 515 | 104 | 0% (0) | None | $54,335 |
| 2017 | 454 | 80 | 0% (0) | None | $52,023 |
| 2016 | 437 | 69 | None | 31% | $50,706 |
| 2015 | 564 | 85 | None | 35% | $54,132 |
| 2014 | 657 | 93 | None | None | $58,526 |
| 2013 | 563 | 95 | None | 26% | $31,959 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Jardiance | 187 | $188,668 | $1,009 |
| Eliquis | 72 | $118,333 | $1,644 |
| Xarelto | 51 | $51,763 | $1,015 |
| Entresto | 29 | $38,789 | $1,338 |
| Atorvastatin | 177 | $6,874 | $39 |
| Metoprolol | 228 | $5,992 | $26 |
| Rosuvastatin | 51 | $3,803 | $75 |
| Ezetimibe | 49 | $3,584 | $73 |
| Losartan | 141 | $3,496 | $25 |
| Clopidogrel | 50 | $2,274 | $45 |
| Amlodipine Besylate | 119 | $2,200 | $18 |
| Lisinopril | 105 | $2,043 | $19 |
| Labetalol | 23 | $1,719 | $75 |
| Hydralazine | 33 | $1,364 | $41 |
| Isosorbide Mononitrate Er | 16 | $1,132 | $71 |
| Chlorthalidone | 22 | $825 | $38 |
| Spironolactone | 56 | $825 | $15 |
| Carvedilol | 27 | $704 | $26 |
| Furosemide | 76 | $622 | $8 |
| Digoxin | 12 | $616 | $51 |
| Omeprazole | 15 | $184 | $12 |
| Hydrochlorothiazide | 41 | $158 | $4 |
2022: 24 drugs
| Eliquis | 81 | $111,670 | $1,379 |
| Jardiance | 44 | $49,547 | $1,126 |
| Xarelto | 47 | $38,748 | $824 |
| Entresto | 29 | $25,010 | $862 |
| Metoprolol | 215 | $6,753 | $31 |
| Atorvastatin | 169 | $5,139 | $30 |
| Ezetimibe | 45 | $2,585 | $57 |
| Losartan | 123 | $2,475 | $20 |
| Labetalol | 27 | $2,168 | $80 |
| Rosuvastatin | 37 | $1,835 | $50 |
| Lisinopril | 118 | $1,689 | $14 |
| Chlorthalidone | 51 | $1,635 | $32 |
| Amlodipine Besylate | 95 | $1,542 | $16 |
| Hydralazine | 41 | $1,381 | $34 |
| Isosorbide Mononitrate Er | 28 | $1,356 | $48 |
| Furosemide | 56 | $1,312 | $23 |
| Clopidogrel | 32 | $1,020 | $32 |
| Carvedilol | 31 | $652 | $21 |
| Digoxin | 14 | $544 | $39 |
| Spironolactone | 48 | $481 | $10 |
| Fenofibrate | 11 | $259 | $24 |
| Metoprolol | 13 | $241 | $19 |
| Omeprazole | 18 | $77 | $4 |
| Hydrochlorothiazide | 16 | $50 | $3 |
2021: 23 drugs
| Eliquis | 62 | $64,204 | $1,036 |
| Xarelto | 41 | $44,086 | $1,075 |
| Entresto | 15 | $12,534 | $836 |
| Metoprolol | 166 | $5,606 | $34 |
| Atorvastatin | 118 | $3,005 | $25 |
| Losartan | 95 | $2,470 | $26 |
| Ezetimibe | 37 | $1,999 | $54 |
| Amlodipine Besylate | 103 | $1,519 | $15 |
| Digoxin | 40 | $1,452 | $36 |
| Rosuvastatin | 39 | $1,372 | $35 |
| Furosemide | 76 | $1,189 | $16 |
| Chlorthalidone | 39 | $1,122 | $29 |
| Carvedilol | 33 | $857 | $26 |
| Lisinopril | 102 | $851 | $8 |
| Diltiazem 24hr Er (Cd) | 13 | $697 | $54 |
| Dilt-Xr | 16 | $639 | $40 |
| Hydralazine | 18 | $552 | $31 |
| Isosorbide Mononitrate Er | 13 | $438 | $34 |
| Metoprolol | 28 | $429 | $15 |
| Spironolactone | 37 | $404 | $11 |
| Clopidogrel | 19 | $229 | $12 |
| Omeprazole | 11 | $122 | $11 |
| Hydrochlorothiazide | 19 | $73 | $4 |
2020: 22 drugs
| Eliquis | 103 | $73,417 | $713 |
| Xarelto | 25 | $25,484 | $1,019 |
| Entresto | 18 | $12,748 | $708 |
| Metoprolol | 170 | $4,192 | $25 |
| Atorvastatin | 88 | $1,341 | $15 |
| Diltiazem 24hr Er (Cd) | 16 | $1,194 | $75 |
| Losartan | 70 | $1,181 | $17 |
| Flecainide Acetate | 15 | $883 | $59 |
| Rosuvastatin | 22 | $774 | $35 |
| Carvedilol | 55 | $719 | $13 |
| Digoxin | 19 | $585 | $31 |
| Amlodipine Besylate | 76 | $561 | $7 |
| Furosemide | 53 | $549 | $10 |
| Lisinopril | 62 | $469 | $8 |
| Dilt-Xr | 13 | $385 | $30 |
| Spironolactone | 36 | $329 | $9 |
| Isosorbide Mononitrate Er | 11 | $328 | $30 |
| Metoprolol | 29 | $219 | $8 |
| Amiodarone | 14 | $199 | $14 |
| Hydralazine | 12 | $199 | $17 |
| Clopidogrel | 17 | $180 | $11 |
| Hydrochlorothiazide | 21 | $92 | $4 |
2019: 25 drugs
| Eliquis | 155 | $78,099 | $504 |
| Xarelto | 30 | $25,542 | $851 |
| Entresto | 29 | $14,389 | $496 |
| Pradaxa | 17 | $8,561 | $504 |
| Diltiazem 24hr Er (Cd) | 33 | $3,877 | $117 |
| Metoprolol | 90 | $1,903 | $21 |
| Flecainide Acetate | 23 | $1,221 | $53 |
| Amiodarone | 31 | $933 | $30 |
| Amlodipine Besylate | 101 | $727 | $7 |
| Atorvastatin | 73 | $695 | $10 |
| Losartan | 51 | $603 | $12 |
| Sotalol | 15 | $496 | $33 |
| Carvedilol | 60 | $479 | $8 |
| Enalapril Maleate | 15 | $451 | $30 |
| Metoprolol | 63 | $424 | $7 |
| Dilt-Xr | 13 | $419 | $32 |
| Diltiazem 24hr Er | 15 | $408 | $27 |
| Cartia Xt | 15 | $304 | $20 |
| Furosemide | 59 | $283 | $5 |
| Lisinopril | 28 | $243 | $9 |
| Hydralazine | 13 | $229 | $18 |
| Hydrochlorothiazide | 53 | $205 | $4 |
| Diltiazem | 13 | $194 | $15 |
| Simvastatin | 12 | $185 | $15 |
| Clopidogrel | 13 | $95 | $7 |
2018: 17 drugs
| Eliquis | 47 | $24,285 | $517 |
| Xarelto | 21 | $11,612 | $553 |
| Diltiazem 24hr Er (Cd) | 22 | $2,207 | $100 |
| Amiodarone | 20 | $1,015 | $51 |
| Flecainide Acetate | 15 | $790 | $53 |
| Metoprolol | 30 | $667 | $22 |
| Atorvastatin | 35 | $507 | $14 |
| Digoxin | 14 | $427 | $31 |
| Dilt-Xr | 15 | $421 | $28 |
| Metoprolol | 31 | $298 | $10 |
| Clopidogrel | 15 | $210 | $14 |
| Furosemide | 37 | $170 | $5 |
| Carvedilol | 34 | $169 | $5 |
| Lisinopril | 29 | $160 | $6 |
| Amlodipine Besylate | 27 | $108 | $4 |
| Losartan | 16 | $107 | $7 |
| Hydrochlorothiazide | 21 | $57 | $3 |
2017: 15 drugs
| Eliquis | 56 | $23,747 | $424 |
| Xarelto | 15 | $9,553 | $637 |
| Pradaxa | 14 | $8,135 | $581 |
| Amiodarone | 25 | $2,357 | $94 |
| Diltiazem 24hr Er | 20 | $1,377 | $69 |
| Flecainide Acetate | 22 | $1,235 | $56 |
| Metoprolol | 36 | $622 | $17 |
| Atorvastatin | 34 | $410 | $12 |
| Dilt-Xr | 11 | $236 | $21 |
| Carvedilol | 23 | $142 | $6 |
| Furosemide | 28 | $138 | $5 |
| Metoprolol | 25 | $131 | $5 |
| Amlodipine Besylate | 16 | $56 | $4 |
| Lisinopril | 12 | $55 | $5 |
| Famotidine | 12 | $45 | $4 |
2016: 14 drugs
| Eliquis | 65 | $25,395 | $391 |
| Pradaxa | 19 | $12,081 | $636 |
| Xarelto | 12 | $4,395 | $366 |
| Diltiazem 24hr Er | 17 | $1,333 | $78 |
| Atorvastatin | 34 | $604 | $18 |
| Dilt-Xr | 17 | $482 | $28 |
| Metoprolol | 24 | $305 | $13 |
| Carvedilol | 32 | $241 | $8 |
| Warfarin | 19 | $202 | $11 |
| Amlodipine Besylate | 21 | $183 | $9 |
| Metoprolol | 17 | $100 | $6 |
| Lisinopril | 19 | $63 | $3 |
| Furosemide | 14 | $35 | $2 |
| Hydrochlorothiazide | 11 | $27 | $2 |
2015: 14 drugs
| Eliquis | 71 | $26,802 | $377 |
| Pradaxa | 43 | $17,543 | $408 |
| Metoprolol | 47 | $1,279 | $27 |
| Amiodarone | 13 | $1,050 | $81 |
| Atorvastatin | 27 | $467 | $17 |
| Carvedilol | 44 | $330 | $7 |
| Potassium Chloride | 11 | $256 | $23 |
| Metoprolol | 31 | $221 | $7 |
| Amlodipine Besylate | 35 | $192 | $5 |
| Simvastatin | 15 | $158 | $11 |
| Furosemide | 54 | $133 | $2 |
| Lisinopril | 24 | $119 | $5 |
| Levothyroxine | 12 | $119 | $10 |
| Clopidogrel | 12 | $67 | $6 |
2014: 19 drugs
| Eliquis | 60 | $19,927 | $332 |
| Pradaxa | 50 | $15,546 | $311 |
| Metoprolol | 30 | $1,231 | $41 |
| Atorvastatin | 36 | $949 | $26 |
| Digox | 17 | $771 | $45 |
| Amiodarone | 13 | $619 | $48 |
| Diltiazem Er | 14 | $503 | $36 |
| Pravastatin | 17 | $469 | $28 |
| Carvedilol | 52 | $407 | $8 |
| Lisinopril | 25 | $346 | $14 |
| Pantoprazole | 26 | $246 | $9 |
| Clopidogrel | 20 | $235 | $12 |
| Amlodipine Besylate | 37 | $193 | $5 |
| Furosemide | 41 | $185 | $5 |
| Simvastatin | 15 | $168 | $11 |
| Metoprolol | 19 | $126 | $7 |
| Lovastatin | 11 | $106 | $10 |
| Atenolol | 18 | $84 | $5 |
| Hydrochlorothiazide | 14 | $72 | $5 |
2013: 18 drugs
| Pradaxa | 29 | $7,626 | $263 |
| Eliquis | 19 | $6,101 | $321 |
| Effient | 13 | $2,941 | $226 |
| Clopidogrel | 14 | $1,306 | $93 |
| Atorvastatin | 30 | $1,054 | $35 |
| Metoprolol | 21 | $943 | $45 |
| Amiodarone | 22 | $597 | $27 |
| Carvedilol | 55 | $567 | $10 |
| Diltiazem Er | 18 | $536 | $30 |
| Amlodipine Besylate | 44 | $425 | $10 |
| Bd Ultra-Fine Pen Needle | 11 | $405 | $37 |
| Losartan | 17 | $306 | $18 |
| Pravastatin | 11 | $270 | $25 |
| Lisinopril | 33 | $240 | $7 |
| Furosemide | 45 | $195 | $4 |
| Metoprolol | 20 | $117 | $6 |
| Warfarin | 13 | $104 | $8 |
| Hydrochlorothiazide | 15 | $89 | $6 |
Money from drug and device companies
$461 in 2025
| 2025 | 3 | 6 | None | $461 |
| 2024 | 1 | 1 | None | $22 |
| 2023 | 2 | 2 | None | $171 |
| 2022 | 3 | 3 | None | $236 |
| 2021 | 1 | 14 | None | $1,434 |
| 2020 | 1 | 1 | None | $27 |
| 2019 | 2 | 2 | None | $42 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotronik | None | $293 | 4 payments
|
| Sanofi-Aventis U.S. | Tzield | $150 | 1 payment
|
| Biosense Webster | None | $19 | 1 payment
|
See all 6 published payments
| Biosense Webster | Meals · 2025-05-20 | None | $19 |
| Sanofi-Aventis U.S. | Meals · 2025-03-19 | Tzield | $150 |
| Biotronik | Meals · 2025-01-11 | None | $43 |
| Biotronik | Meals · 2025-01-11 | None | $97 |
| Biotronik | Meals · 2025-01-11 | None | $128 |
| Biotronik | Meals · 2025-01-11 | None | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $22
| Merck Sharp & Dohme | Bridion | $22 | 1 payment
|
2023: $171
| Abbott Laboratories | Freestyle Libre 3 | $146 | 1 payment
|
| Medtronic | Reveal Linq | $26 | 1 payment
|
2022: $236
| Medtronic | Cobalt Dr Mri Surescan | $149 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $73 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $13 | 1 payment
|
2021: $1,434
| Medtronic | Linq II | $1,434 | 14 payments
|
2020: $27
| Abiomed | Impella | $27 | 1 payment
|
2019: $42
| Medtronic Vascular | Claria Mri | $26 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $16 | 1 payment
|
Professional record
- NPI
- 1528080256
- Licence
- CA A72359California A72359: Current · expires 2027-11-30
- Group
- County of San Mateo · Altru Health System · St. Luke'S Hospital of Duluth
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 177 Telles Ln, Fremont, CA, 94539
- NPI first listed
- 2006-07-24
- NPI last updated
- 2020-09-21
- NPI record certified
- 2020-09-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1001 E Superior St Ste L201, Duluth, MN, 55802 · 1300 S Columbia Rd, Grand Forks, ND, 58201